Eli Lilly (LLY) EBT (2009 - 2026)
Eli Lilly (LLY) reported EBT of $9.25 billion for Q2 2026, up 36.4% from $6.78 billion a year earlier and up 4.5% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eli Lilly's EBT came in at $33.6 billion, up 99.3% year-over-year; for FY2025, it came in at $25.73 billion, up 102.9% from FY2024.
- EBT has a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- By year, EBT came in at $12.68 billion in FY2024 (+93.5%), $6.55 billion in FY2023 (-3.7%), $6.81 billion in FY2022 (+10.6%) and $6.16 billion in FY2021 (-14.9%).
- The Q2 2026 figure ranks as the highest quarterly EBT in data going back to Q1 2009.
- Year over year, EBT has now increased in each of the last 11 quarters, with growth averaging 139.2% over the last eight quarters.
- The high point for year-over-year EBT in five years was Q3 2025 (growth of 355.3%); the low point was Q3 2023 (a decline of 72.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.85 billion (Q1 2026), $8.27 billion (Q4 2025) and $7.23 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Vertex Pharmaceuticals | 131.15 Bn | 103.16 Bn | 2.84 Bn | 1.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.25 Bn |
| Mar 31, 2026 | 8.85 Bn |
| Dec 31, 2025 | 8.27 Bn |
| Sep 30, 2025 | 7.23 Bn |
| Jun 30, 2025 | 6.78 Bn |
| Mar 31, 2025 | 3.46 Bn |
| Dec 31, 2024 | 5.04 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Jun 30, 2024 | 3.52 Bn |
| Mar 31, 2024 | 2.54 Bn |
| Dec 31, 2023 | 2.51 Bn |
| Sep 30, 2023 | 427.20 Mn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 1.53 Bn |
| Dec 31, 2022 | 2.10 Bn |
| Sep 30, 2022 | 1.57 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 2.05 Bn |
| Dec 31, 2021 | 1.84 Bn |
| Sep 30, 2021 | 1.25 Bn |
API Access
Eli Lilly EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();